Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
6981 studies found for:    "Breast Neoplasms"
Show Display Options
Rank Status Study
21 Completed
Has Results
Vinflunine Plus Trastuzumab in Human Epidermal Growth Factor Receptor 2 (HER2neu) Over-Expressing Metastatic Breast Cancer
Conditions: Breast Neoplasms;   Breast Cancer
Interventions: Drug: Vinflunine;   Drug: Trastuzumab
22 Recruiting Chloroquine With Taxane Chemotherapy for Advanced or Metastatic Breast Cancer Patients Who Have Failed an Anthracycline (CAT)
Conditions: Breast Neoplasms;   Breast Cancer
Interventions: Drug: Taxane;   Drug: Taxotere;   Drug: Abraxane;   Drug: Ixabepilone
23 Active, not recruiting Abraxane With or Without Tigatuzumab in Patients With Metastatic, Triple Negative Breast Cancer
Conditions: Breast Cancer;   Triple Negative Breast Cancer;   Stage IV Breast Cancer;   Metastatic Breast Cancer
Interventions: Drug: Abraxane;   Drug: Tigatuzumab
24 Completed Safety and Efficacy Study of a New Chemotherapy Agent to Treat Metastatic Breast Cancer
Conditions: Breast Neoplasms;   Breast Cancer, Metastatic
Intervention: Drug: Sagopilone (BAY86-5302, ZK 219477)
25 Terminated Safety and Efficacy Study of the Trifunctional Antibody Ertumaxomab to Treat Patients With Advanced or Metastatic Breast Cancer
Conditions: Breast Neoplasms;   Breast Cancer
Intervention: Drug: ertumaxomab
26 Active, not recruiting Vaccine Therapy in Combination With Rintatolimod and/or Sargramostim in Treating Patients With Stage II-IV HER2-Positive Breast Cancer
Conditions: HER2-positive Breast Cancer;   Male Breast Cancer;   Recurrent Breast Cancer;   Stage II Breast Cancer;   Stage IIIA Breast Cancer;   Stage IIIB Breast Cancer;   Stage IIIC Breast Cancer;   Stage IV Breast Cancer
Interventions: Biological: HER-2/neu peptide vaccine;   Biological: sargramostim;   Drug: rintatolimod;   Other: laboratory biomarker analysis
27 Completed Study of XL147 (SAR245408) in Combination With Trastuzumab or Paclitaxel and Trastuzumab in Subjects With Metastatic Breast Cancer Who Have Progressed on a Previous Trastuzumab-based Regimen
Conditions: Breast Cancer;   Breast Neoplasms
Interventions: Drug: XL147 (SAR245408);   Biological: trastuzumab;   Drug: paclitaxel
28 Active, not recruiting Eribulin Versus Vinorelbine in Subjects With Locally Recurrent or Metastatic Breast Cancer Previously Treated With Anthracyclines and Taxanes
Conditions: HER2-Negative Breast Cancer;   Triple Negative Breast Cancer;   Breast Cancer;   Cancer of Breast;   Breast Tumors
Interventions: Drug: E7389 (Eribulin Mesylate);   Drug: Vinorelbine injection
29 Recruiting Phase 2 Study of Standard Chemotherapy With Trastuzumab, Plus or Minus Pertuzumab, for Pre-treated Metastatic Breast Cancer
Conditions: Breast Neoplasms;   Malignant Tumor of the Breast
Interventions: Drug: Trastuzumab;   Drug: Pertuzumab;   Drug: Vinorelbine, Paclitaxel, Nab-Paclitaxel , Docetaxel, Capecitabine
30 Completed
Has Results
Imiquimod for Breast Cancer Patients With Chest Wall Recurrence or Skin Metastases
Conditions: Breast Cancer;   Breast Neoplasms
Intervention: Drug: Imiquimod
31 Completed
Has Results
Pemetrexed Plus Gemcitabine in Metastatic Breast Cancer Patients After Receiving Taxane Therapy
Conditions: Breast Cancer;   Breast Neoplasms
Interventions: Drug: Pemetrexed;   Drug: Gemcitabine
32 Completed Study to Evaluate Exemestane With and Without SNDX-275 in Treatment of Postmenopausal Women With Advanced Breast Cancer
Conditions: Breast Cancer;   Estrogen Receptor-Positive Breast Cancer;   Breast Cancer, Estrogen Receptor-Positive;   ER+ Breast Cancer
Interventions: Drug: entinostat;   Drug: exemestane
33 Not yet recruiting Talimogene Laherparepvec in Combination With Neoadjuvant Chemotherapy in Triple Negative Breast Cancer
Conditions: Breast Cancer;   Ductal Carcinoma;   Invasive Breast Carcinoma;   Invasive Ductal Breast Carcinoma
Interventions: Biological: Talimogene laherparepvec;   Drug: Paclitaxel
34 Not yet recruiting A Breast Cancer Treatment Decision Aid for Women Aged 70 and Older
Conditions: Breast Cancer;   Estrogen Receptor Positive Breast Cancer;   Node-negative Breast Cancer;   Human Epidermal Growth Factor 2 Negative Carcinoma of Breast
Interventions: Other: Breast Cancer Treatment Decision Aid for women 70+;   Other: Usual Care
35 Completed
Has Results
Primary Chemotherapy With Docetaxel-Capecitabine and Doxorubicin-Cyclophosphamide in Breast Cancer
Conditions: Breast Cancer;   Breast Neoplasm
Interventions: Drug: Docetaxel - Dose A;   Drug: Anastrozole;   Drug: cyclophosphamide;   Drug: Docetaxel - Dose B;   Drug: Doxorubicin hydrochloride;   Drug: Tamoxifen Citrate;   Drug: Capecitabine - Dose B;   Drug: Capecitabine - Dose A
36 Completed
Has Results
Bevacizumab Given With Either Anastrozole or Fulvestrant With Trastuzumab for Postmenopausal Metastatic Breast Cancer
Conditions: Breast Cancer;   Breast Neoplasms
Interventions: Drug: Bevacizumab;   Drug: Anastrozole;   Drug: Fulvestrant
37 Recruiting Hypofractionated Regional Nodal Irradiation Clinical Trial for Women With Breast Cancer
Conditions: Breast Cancer;   Node-positive Breast Cancer;   Breast Adenocarcinoma;   Invasive Breast Carcinoma;   Lobular Breast Carcinoma In Situ
Interventions: Radiation: External Beam Radiation Therapy;   Other: Questionnaire Administration;   Other: Laboratory Biomarker Analysis
38 Terminated Efficacy and Safety of IPI-504 With Trastuzumab Pretreated, Locally Advanced or Metastatic HER2 Positive Breast Cancer
Conditions: Breast Cancer;   HER2 Positive Breast Cancer;   Metastatic Breast Cancer;   Cancer of the Breast
Interventions: Drug: IPI-504;   Drug: Trastuzumab
39 Recruiting Ruxolitinib in Combination With Trastuzumab in Metastatic HER2 Positive Breast Cancer
Conditions: Metastatic Breast Cancer;   Breast Carcinoma;   HER-2 Positive Breast Cancer
Interventions: Drug: Ruxolitinib;   Drug: Trastuzumab
40 Recruiting Window of Opportunity Trial of Dasatinib in Operable Triple Negative Breast Cancers With nEGFR
Conditions: Breast Neoplasms;   Triple Negative Breast Neoplasms
Interventions: Drug: Dasatinib;   Procedure: Conventional Surgery;   Other: Laboratory Biomarker Analysis

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years